321 related articles for article (PubMed ID: 16687136)
1. Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol.
Williams IJ; Edwards S; Rubo A; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2006 Jun; 539(1-2):57-63. PubMed ID: 16687136
[TBL] [Abstract][Full Text] [Related]
2. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
3. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
4. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
5. Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Jul; 567(1-2):125-30. PubMed ID: 17498686
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9-tetrahydrocannabinol.
Cichewicz DL; Welch SP; Smith FL
Eur J Pharmacol; 2005 Nov; 525(1-3):74-82. PubMed ID: 16288738
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration.
Cichewicz DL; McCarthy EA
J Pharmacol Exp Ther; 2003 Mar; 304(3):1010-5. PubMed ID: 12604676
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
Frederickson RC; Hewes CR; Aiken JW
J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
[TBL] [Abstract][Full Text] [Related]
9. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.
Cadoni C; Pisanu A; Solinas M; Acquas E; Di Chiara G
Psychopharmacology (Berl); 2001 Nov; 158(3):259-66. PubMed ID: 11713615
[TBL] [Abstract][Full Text] [Related]
10. The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.
Pugh G; Smith PB; Dombrowski DS; Welch SP
J Pharmacol Exp Ther; 1996 Nov; 279(2):608-16. PubMed ID: 8930163
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
Jardinaud F; Roques BP; Noble F
Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
[TBL] [Abstract][Full Text] [Related]
12. Propofol sedation is reduced by delta9-tetrahydrocannabinol in mice.
Brand PA; Paris A; Bein B; Meybohm P; Scholz J; Ohnesorge H; Tonner PH
Anesth Analg; 2008 Jul; 107(1):102-6. PubMed ID: 18635473
[TBL] [Abstract][Full Text] [Related]
13. DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine.
Cheng HY; Laviolette SR; van der Kooy D; Penninger JM
Eur J Neurosci; 2004 Jun; 19(11):3033-41. PubMed ID: 15182311
[TBL] [Abstract][Full Text] [Related]
14. The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol.
Smith FL; Cichewicz D; Martin ZL; Welch SP
Pharmacol Biochem Behav; 1998 Jun; 60(2):559-66. PubMed ID: 9632241
[TBL] [Abstract][Full Text] [Related]
15. The effect of delta9-tetrahydrocannabinol on the conversion of [3H]trypotphan to 5-[3H] hydroxytryptamine in the mouse brain.
Johnson KM; Dewey WL
J Pharmacol Exp Ther; 1978 Oct; 207(1):140-50. PubMed ID: 702335
[TBL] [Abstract][Full Text] [Related]
16. Profound hypothermia in mammals treated with tetrahydrocannabinols, morphine, or chlorpromazine.
Haavik CO
Fed Proc; 1977 Nov; 36(12):2595-8. PubMed ID: 913617
[TBL] [Abstract][Full Text] [Related]
17. Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.
Roberts JD; Gennings C; Shih M
Eur J Pharmacol; 2006 Jan; 530(1-2):54-8. PubMed ID: 16375890
[TBL] [Abstract][Full Text] [Related]
18. Effects of ephedrine and phenylpropanolamine on the antinociceptive effects of morphine and codeine in mice.
Dambisya YM; Wong CL; Chan K
Arch Int Pharmacodyn Ther; 1990; 308():5-12. PubMed ID: 2099137
[TBL] [Abstract][Full Text] [Related]
19. Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription.
Khare M; Taylor AH; Konje JC; Bell SC
Mol Hum Reprod; 2006 May; 12(5):321-33. PubMed ID: 16597638
[TBL] [Abstract][Full Text] [Related]
20. Increasing the selectivity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol: complete substitution with methanandamide.
Alici T; Appel JB
Pharmacol Biochem Behav; 2004 Nov; 79(3):431-7. PubMed ID: 15582014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
